These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25261936)

  • 81. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.
    Muinelo-Romay L; Colas E; Barbazan J; Alonso-Alconada L; Alonso-Nocelo M; Bouso M; Curiel T; Cueva J; Anido U; Forteza J; Gil-Moreno A; Reventos J; Lopez-Lopez R; Abal M
    Mol Cancer Ther; 2011 Aug; 10(8):1357-66. PubMed ID: 21613448
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
    Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
    Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 84. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 85. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
    Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
    Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
    [TBL] [Abstract][Full Text] [Related]  

  • 87. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
    Papadaki MA; Kallergi G; Zafeiriou Z; Manouras L; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    BMC Cancer; 2014 Sep; 14():651. PubMed ID: 25182808
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Looking back, to the future of circulating tumor cells.
    Friedlander TW; Premasekharan G; Paris PL
    Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.
    Marín-Aguilera M; Codony-Servat J; Reig Ò; Lozano JJ; Fernández PL; Pereira MV; Jiménez N; Donovan M; Puig P; Mengual L; Bermudo R; Font A; Gallardo E; Ribal MJ; Alcaraz A; Gascón P; Mellado B
    Mol Cancer Ther; 2014 May; 13(5):1270-84. PubMed ID: 24659820
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Epithelial to mesenchymal plasticity: role in cancer progression.
    Raja R; Pandey A; Kumar P
    Front Biosci (Landmark Ed); 2020 Jan; 25(5):838-873. PubMed ID: 31585920
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Phenotypic Transitions the Processes Involved in Regulation of Growth and Proangiogenic Properties of Stem Cells, Cancer Stem Cells and Circulating Tumor Cells.
    Kulus M; Farzaneh M; Bryja A; Zehtabi M; Azizidoost S; Abouali Gale Dari M; Golcar-Narenji A; Ziemak H; Chwarzyński M; Piotrowska-Kempisty H; Dzięgiel P; Zabel M; Mozdziak P; Bukowska D; Kempisty B; Antosik P
    Stem Cell Rev Rep; 2024 May; 20(4):967-979. PubMed ID: 38372877
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.
    Barbazán J; Alonso-Alconada L; Muinelo-Romay L; Vieito M; Abalo A; Alonso-Nocelo M; Candamio S; Gallardo E; Fernández B; Abdulkader I; de Los Ángeles Casares M; Gómez-Tato A; López-López R; Abal M
    PLoS One; 2012; 7(7):e40476. PubMed ID: 22811761
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
    Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C
    Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844
    [TBL] [Abstract][Full Text] [Related]  

  • 100. DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution.
    Zhao L; Wu X; Zheng J; Dong D
    Oncogene; 2021 Mar; 40(10):1884-1895. PubMed ID: 33564067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.